LENZ vs MSFT: Which Stock is Better?
Side-by-side comparison of Lenz Therapeutics Inc and Microsoft Corp in 2026
LENZ
Lenz Therapeutics Inc
$10.18
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | LENZ | MSFT | Winner |
|---|---|---|---|
| Market Cap | $319.19M | N/A | LENZ |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 97.8% | 68.6% | LENZ |
Analyze LENZ
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LENZ or MSFT a better investment?
Comparing LENZ and MSFT: Lenz Therapeutics Inc has a market cap of $319.19M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LENZ and MSFT?
LENZ (Lenz Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LENZ or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LENZ or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for LENZ.
Which company is more profitable: LENZ or MSFT?
Lenz Therapeutics Inc (LENZ) has higher gross margins at 97.8% compared to 68.6% for MSFT.
Which is the larger company: LENZ or MSFT?
Lenz Therapeutics Inc (LENZ) is larger with a market cap of $319.19M compared to N/A for MSFT.
Should I buy LENZ or MSFT in 2026?
Both LENZ and MSFT have investment merit. LENZ trades at $10.18 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LENZ and MSFT stock?
Key differences: Market Cap ($319.19M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (97.8% vs 68.6%).